Silica-based cerium (III) chloride nanoparticles prevent the fructose-induced glycation of α-crystallin and H2O 2-induced oxidative stress in human lens epithelial cells

Archives of Pharmacal Research

Volumn 37, Issue 3, 2014, Pages 404-411

  Yang, Jin ^a   Cai, Lei ^a   Zhang, Sen ^b   Zhu, Xiangjia ^a   Zhou, Peng ^a   Lu, Yi ^a  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

AGEs; Cataractogenesis; Chaperone activity; Glycation; Crystallin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA CRYSTALLIN; AMINOGUANIDINE; ANTIOXIDANT; CHAPERONE; FRUCTOSE; GLUTATHIONE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICA CERIUM CHLORIDE; UNCLASSIFIED DRUG; CERIUM; CEROUS CHLORIDE; HYDROGEN PEROXIDE; METAL NANOPARTICLE; SILICON DIOXIDE;

ADSORPTION; ARTICLE; CATARACT; CELL CULTURE; CONJUGATION; CONTROLLED STUDY; EPITHELIUM CELL; GLYCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LENS EPITHELIUM; OXIDATIVE STRESS; SPECTROMETRY; ULTRAVIOLET RADIATION; ANIMAL; BOVINE; DRUG EFFECTS; GLYCOSYLATION; LENS; METABOLISM; PHYSIOLOGY;

ALPHA-CRYSTALLINS; ANIMALS; CATTLE; CELLS, CULTURED; CERIUM; EPITHELIAL CELLS; FRUCTOSE; GLYCOSYLATION; HUMANS; HYDROGEN PEROXIDE; LENS, CRYSTALLINE; METAL NANOPARTICLES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE;

EID: 84896403486     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0195-2     Document Type: Article

References (32)

1. Campbell, C.T.; and C.H. Peden. 2005. Chemistry. Oxygen vacancies and catalysis on ceria surfaces. Science 309: 713-714.
2. Celardo, I.; J.Z. Pedersen, E. Traversa, and L. Ghibelli. 2011. Pharmacological potential of cerium oxide nanoparticles. Nanoscale 3: 1411-1420.
3. Das, M.; S. Patil, N. Bhargava, J.F. Kang, L.M. Riedel, S. Seal, and J.J. Hickman. 2007. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28: 1918-1925.
4. Harding, J.J. 2002. Viewing molecular mechanisms of ageing through a lens. Ageing Research Reviews 1: 465-479.
5. Hipkiss, A.R.; and C. Brownson. 2000. A possible new role for the anti-ageing peptide carnosine. Cellular and Molecular Life Sciences 57: 747-753.
6. Hipkiss, A.R.; C. Brownson, and M.J. Carrier. 2001. Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mechanisms of Ageing and Development 122: 1431-1445.
7. Hipkiss, A.R.; J. Michaelis, and P. Syrris. 1995. Non-enzymatic glycosylation of the dipeptide l-carnosine, a potential anti-protein-cross- linking agent. FEBS Letters 371: 81-85.
8. Inerbaev, T.M.; S. Seal, and A.E. Masunov. 2010. Density functional study of oxygen vacancy formation and spin density distribution in octahedral ceria nanoparticles. Journal of Molecular Modeling 16: 1617-1623.
9. Karakoti, A.; S. Singh, J.M. Dowding, S. Seal, and W.T. Self. 2010. Redox-active radical scavenging nanomaterials. Chemical Society Reviews 39: 4422-4432.
10. Korsvik, C.; S. Patil, S. Seal, and W.T. Self. 2007. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chemical Communications (Cambridge) 10: 1056-1058.
11. Kyselova, Z.; M. Stefek, and V. Bauer. 2004. Pharmacological prevention of diabetic cataract. Journal of Diabetes and Its Complications 18: 129-140.
12. Mcgreal, R.S.; W. Lee Kantorow, D.C. Chauss, J. Wei, L.A. Brennan, and M. Kantorow. 2012. alphaB-crystallin/sHSP protects cytochrome c and mitochondrial function against oxidative stress in lens and retinal cells. Biochimica et Biophysica Acta 1820: 921-930.
13. Monnier, V.M.; D.R. Sell, R.H. Nagaraj, S. Miyata, S. Grandhee, P. Odetti, and S.A. Ibrahim. 1992. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41(Suppl 2): 36-41.
14. Nass, N.; B. Bartling, A. Navarrete Santos, R.J. Scheubel, J. Borgermann, R.E. Silber, and A. Simm. 2007. Advanced glycation end products, diabetes and ageing. Zeitschrift fur Gerontologie und Geriatrie 40: 349-356.
15. Olofsson, E.M.; S.L. Marklund, and A. Behndig. 2012. Enhanced age-related cataract in copper-zinc superoxide dismutase null mice. Clinical and Experimental Ophthalmology 40(8): 813-820.
16. Patil, S.; S. Reshetnikov, M.K. Haldar, S. Seal, and S. Mallik. 2007. Surface-derivatized nanoceria with human carbonic anhydrase II inhibitors and fluorophores: A potential drug delivery device. The Journal of Physical Chemistry C 111: 8437-8442.
17. Pierscionek, B.K.; Y. Li, A.A. Yasseen, L.M. Colhoun, R.A. Schachar, and W. Chen. 2010. Nanoceria have no genotoxic effect on human lens epithelial cells. Nanotechnology 21: 035102.
18. Pirmohamed, T.; J.M. Dowding, S. Singh, B. Wasserman, E. Heckert, A.S. Karakoti, J.E. King, S. Seal, and W.T. Self. 2010. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chemical Communications (Cambridge, England) 46: 2736-2738.
19. Puddu, A.; D. Storace, P. Odetti, and G. Viviani. 2010. Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochemical and Biophysical Research Communications 395: 122-125.
20. Quillen, D.A. 1999. Common causes of vision loss in elderly patients. American Family Physician 60: 99.
21. Schachar, R.A.; W. Chen, B.K. Woo, B.K. Pierscionek, X. Zhang, and L. Ma. 2008. Diffusion of nanoparticles into the capsule and cortex of a crystalline lens. Nanotechnology 19: 025102.
22. Seneviratne, C.; R. Narayanan, W. Liu, and J. Dain. 2012. The in vitro inhibition effect of 2 nm gold nanoparticles on non-enzymatic glycation of human serum albumin. Biochemical and Biophysical Research Communications 422: 447-454.
23. Singha, S.; J. Bhattacharya, H. Datta, and A.K. Dasgupta. 2009. Anti-glycation activity of gold nanoparticles. Nanomedicine 5: 21-29.
24. Stitt, A.W. 2005. The Maillard reaction in eye diseases. Annals of the New York Academy of Sciences 1043: 582-597.
25. Swamy-Mruthinti, S.; K. Green, and E.C. Abraham. 1996. Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Experimental Eye Research 62: 505-510.
26. Szwergold, B.S. 2005. Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochemical and Biophysical Research Communications 336: 36-41.
27. Wang, K.; R. Li, Y. Cheng, and B. Zhu. 1999. Lanthanides - the future drugs? Coordination Chemistry Reviews 190-192: 297-308.
28. Watson, G.W.; and U.P. Andley. 2010. Activation of the unfolded protein response by a cataract-associated αA-crystallin mutation. Biochemical and Biophysical Research Communications 401: 192-196.
29. Wong, L.L.; S.M. Hirst, Q.N. Pye, C.M. Reilly, S. Seal, and J.F. Mcginnis. 2013. Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection. PLoS ONE 8: e58431.
30. Yan, H.; and J.J. Harding. 2006. Carnosine inhibits modifications and decreased molecular chaperone activity of lens alpha-crystallin induced by ribose and fructose 6-phosphate. Molecular Vision 12: 205-214.
31. Yan, S.F.; S.D. Yan, K. Herold, R. Ramsamy, and A.M. Schmidt. 2006. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing. Endocrinology and Metabolism Clinics of North America 35: 511-524. viii.
32. Zielhuis, S.W.; J.H. Seppenwoolde, V.A. Mateus, C.J. Bakker, G.C. Krijger, G. Storm, B.A. Zonnenberg, A.D. Van Het Schip, G.A. Koning, and J.F. Nijsen. 2006. Lanthanide-loaded liposomes for multimodality imaging and therapy. Cancer Biotherapy and Radiopharmaceuticals 21: 520-527.